Ebit Zmiana Data
AbbVie USD 4.52B 378M 2023-09
Abbott USD 1.93B 147M 2023-12
Amgen USD 1.8B 254M 2023-12
AstraZeneca USD 2.15B 418M 2023-09
Avrobio USD -21091000 5.36M 2023-09
BioCryst Pharmaceuticals USD -11921000 8.78M 2023-09
Bristol-Myers Squibb USD 2.61B 104M 2023-12
Eli Lilly USD 3.08B 347.4M 2023-12
Enanta Pharmaceuticals USD -31030000 5.68M 2023-09
GlaxoSmithKline GBP 2.59B 602M 2023-09
Incyte USD 205.23M 10.1M 2023-12
J&J USD 5.31B 1.21B 2023-12
Merck USD -299000000 6.8B 2023-12
Nektar Therapeutics USD -33504000 541K 2023-09
Pfizer USD -125000000 2.34B 2023-12
Regeneron Pharmaceuticals USD 1B 208.1M 2023-12
Roche Holding CHF 10.6B 2.12B 2023-06
Takeda JPY -49342000000 217.91B 2023-09
TG Therapeutics USD -12485000 127.27M 2023-12
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Xencor USD -34509000 16.44M 2023-12



Karyopharm Therapeutics - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.